ContraVir stock: buy or sell?
June 26th, 2019
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections.
Should I buy ContraVir stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with ContraVir stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is ContraVir Pharmaceuticals stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we found 1 rating published for CTRV stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
ContraVir stock analysis
Shares of ContraVir Pharmaceuticals plummed a bloodcurdling -9.61% and closed at $4.14.
ContraVir Pharmaceuticals plummed a bloodcurdling -9.61% and closed at $4.14. Since price and SMA50d lines crossed down on April, CTRV fell $-13.29 per share (-76.25%).
ContraVir Pharmaceuticals shares plunged -20.38% this week, ending at $4.14. By mid June CTRV boosted an outstanding 10.24% in just one week.
Since price and 10-weeks moving average lines crossed down last week, CTRV fell $-4.75 per share (-53.43%).
ContraVir stock price history
ContraVir stock went public on February 20th, 2014 with a price of $840.001. Since then, CTRV stock sliced a -99.50%, with a yearly average of -19.90%.
1: Adjusted price after possible price splits or reverse-splits.
ContraVir stock historical price chart
CTRV stock reached 52-week highs at $182.00, and all-time highs 2015-10-05 with a price of 3516.8.
ContraVir stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' CTRV stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price forecast for ContraVir stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on November, ContraVir Pharmaceuticals . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn , ContraVir annual turnover to M dollars from marked in . , its profit margin (compared to revenues) to , that is million.
Quarterly financial resultsReported quarter income marked $-0.16 M with a profit margin of . Profit margin remained stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, ContraVir sales marked a neutral movement and remained constant a nan%. Looking back to recent quarterly results, ContraVir Pharmaceuticals posted 2 positive quarters in a row.
ContraVir ownershipWhen you are planning to buy shares of a stock, it's always worth to have a look its ownership structure.
ContraVir shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 36.42% of all shares.
In case of ContraVir stock, 3.72% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CTRV stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to ContraVir Pharmaceuticals:
|Market cap||$2.4 M|
|Total shares||0.6 M|
|Float shares||0.5 M|
|- Institutional holdings (%)||3.7%|
|- Insider holdings (%)||36.4%|
|Shares in short selling||0.0%|
|Wednesday, June 26th, 2019|
|Day range||$4.05 - $4.58|
|Average true range||$2.78|
|50d mov avg||$8.79|
|100d mov avg||$13.15|
|200d mov avg||$25.73|
ContraVir performanceTo measure stock performance is always good to compare with competitors or related stocks. In the following table, we compare ContraVir performance to :